Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Lisa, Carey"'
Autor:
Karen McKinnon, Kristen Cowens, Dante Bortone, Lisa Carey, Trevor Jolly, Hyman Muss, Katherine Reeder-Hayes, Rebecca Kaltman, Rachel Jankowitz, Vinay Gudena, Oludamilola Olajide, Charles Perou, Carey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, Dominic T Moore, Maria J Sambade, Sonia Laurie, Alexander Robeson, Oleg Kolupaev, Luz A Cuaboy, Amy L Garrett, Benjamin C Calhoun, Alec D Wilkinson, E Claire Dees, Benjamin G Vincent, Jonathan S Serody
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
Externí odkaz:
https://doaj.org/article/4b4477f689454bc2b5fe6bd317c412e0
Autor:
Joseph J. Connolly, Laura M. Spring, Alphonse G. Taghian, Michele Gadd, Laura Warren, Ana C. Garrido-Castro, Tari King, Elizabeth A. Mittendorf, Jose P. Leone, Dana L. Casey, Lisa Carey, Tiffany A. Traina, Yara Abdou, Atif Khan, George Plitas, Jean Wright, Cesar Augusto Santa-Maria, Lisa Jacobs, Rachel Blitzblau, E Shelley Hwang, Carey Anders, Ian Krop, Antonio C. Wolff, Alastair M. Thompson, Elyssa Denault, Gaorav Gupta, Alice Ho
Publikováno v:
Cancer Research. 83:OT3-15
Background: The introduction of immune checkpoint inhibitors (ICI) to standard neoadjuvant chemotherapy regimens has been shown to significantly improve outcomes in patients with triple negative breast cancer and is being investigated for high-risk h
Autor:
Heather A. Parsons, Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana Abramson, Ashka Patel, Ju Cheng, Adam M. Brufsky, Justin Rhoades, Jeremy Force, Ruolin Liu, Tiffany A. Traina, Lisa Carey, Mothaffar Rimawi, Ahmed Elkhanany, Vered Stearns, Jennifer M. Specht, Harold Burstein, Antonio C. Wolff, Eric Winer, Nabihah Tayob, Ian Krop, Todd Golub, Erica L. Mayer, Viktor Adalsteinsson
Publikováno v:
Cancer Research. 83:PD11-06
Background. Patients (pts) with early triple negative breast cancer (eTNBC) are at increased risk of breast cancer recurrence and death. Recent studies have focused on escalation of therapy, with current treatment standard of at least five drugs –
Autor:
Otto Metzger, Christina Herold, Coralie Poncet, Heidi De Swert, Jose Casas-Martin, Ann Partridge, Samia Guita, Lisa Carey, Eva Schumacher, Theodora Goulioti, Thomas Meyskens, Joseph Gannon, Khadija Benlhassan, Giovanna Rossi, Eleni Xenophontos, Amal Arahmani, Amylou C. Dueck, Gautier Paux, Etienne Brain, David A. Cameron
Publikováno v:
Cancer Research. 83:OT1-04
Background: About 30% of patients (pts) with hormone receptor (HR)-positive early breast cancer (EBC) on adjuvant aromatase inhibitor (AI) therapy discontinue due to toxicity with 22% of pts discontinuing during the first year (Henry et al. JCO 2012)
Autor:
Sanah Vohra, Sarah Van Alsten, Joannie M. Ivory, Alina Hamilton, Xiaohua Gao, Erin Kirk, Joseph Nsonwu-Farley, Ebonee Butler, Brianna Taffe, Charles M. Perou, Lisa Carey, Melissa Troester
Publikováno v:
Cancer Research. 83:PD1-08
Background: Black and younger women have poorer breast cancer outcomes. Using a diverse population-based study, we examined the role of biology as measured by genomic assays in outcome disparity among clinically HR+/HER2- women. Methods: Data and bio
Autor:
Cherie Kuzmiak, Terry S. Hartman, Thad Benefield, Joseph Peterson, Anuja K. Antony, Tushar Pandey, John A. Cole, Benjaminc C. Calhoun, Lisa Carey
Publikováno v:
Cancer Research. 83:P1-04
Background: As pathologic complete response (pCR) is correlated with higher rates of event free survival, accurately forecasting pCR advances our collective endeavors in precision oncology to discern and translate individual patient-specific data int
Autor:
Benjamin Vincent, Dominic Moore, Mark Woodcock, Carey Anders, Amanda Van Swearingen, Maria Sambade, Luz Cuaboy, Amy Garrett, Karen McKinnon, Kristen Cowens, Dante Bortone, Benjamin Calhoun, Lisa Carey, Claire Dees, Trevor Jolly, Hyman Muss, Katherine Reeder-Hayes, Rebecca Kaltman, Rachel Jankowitz, Vinay Gudena, Oludamilola Olajide, Charles Perou, Jonathan Serody
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/66ceae14360c4fa2897157a5c2f6fcac
Autor:
Lisa Carey Lohmueller, Aakanksha Naik, Luke Breitfeller, Colleen K. McIlvennan, Manreet Kanwar, Srinivas Murali, Carolyn Rosé, James F. Antaki
Publikováno v:
MDM Policy & Practice, Vol 4 (2019)
Background. The decision to receive a permanent left ventricular assist device (LVAD) to treat end-stage heart failure (HF) involves understanding and weighing the risks and benefits of a highly invasive treatment. The goal of this study was to chara
Externí odkaz:
https://doaj.org/article/35cea6379ea04778af670c859a59dcad
Autor:
Vincent L. Cryns, Carey K. Anders, Eric V. Shusta, Lisa Carey, Matt Ewend, Joseph Geradts, Kimberly Blackwell, Erika Hamilton, Karen Fritchie, Chad Livasy, Andrey Ugolkov, C. Ryan Miller, Barbara Adamo, Abraham Al Ahmad, Allison M. Deal, Vladimir Petrovic, Elena Strekalova, Dmitry Malin
PDF file - 797K, Figure S1. Barrier phenotype of human brain microvascular endothelial cells and astrocytes in monocultures and co-cultures. Figure S2. alpha/beta-crystallin does not affect cell viability of TNBC cells in standard monolayer culture.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::037114286fb81617e95760c4df77ea6b
https://doi.org/10.1158/1078-0432.22450124
https://doi.org/10.1158/1078-0432.22450124
Autor:
Vincent L. Cryns, Carey K. Anders, Eric V. Shusta, Lisa Carey, Matt Ewend, Joseph Geradts, Kimberly Blackwell, Erika Hamilton, Karen Fritchie, Chad Livasy, Andrey Ugolkov, C. Ryan Miller, Barbara Adamo, Abraham Al Ahmad, Allison M. Deal, Vladimir Petrovic, Elena Strekalova, Dmitry Malin
Purpose: Basal-like breast tumors are typically (ER/PR/HER2) triple-negative and are associated with a high incidence of brain metastases and poor clinical outcomes. The molecular chaperone αB-crystallin is predominantly expressed in triple-negative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::266e61780d81213be1d293febd4331de
https://doi.org/10.1158/1078-0432.c.6521858
https://doi.org/10.1158/1078-0432.c.6521858